Filing metadata

Accession number
0001209191-23-018721
Form type
Form 4
Filer
Jounce Therapeutics, Inc.
CIK
CIK 1640455
Filed
Mar 14, 2023
Reporting period
Mar 13, 2023
Description
Insider transaction

Explore SEC Filings Hub